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Background: Women and men have diverse responses to many infectious diseases. These differences are amplified
following menopause. However, despite extensive information regarding the effects of sex hormones on immune
cells, our knowledge is limited regarding the effects of sex and gender on the function of the mucosal immune
system. Sex differences also manifest in the prevalence of gut associated inflammatory and autoimmune disorders,
including Crohn’s disease, ulcerative colitis and Celiac disease. It is thus hypothesized that a baseline sex-associated
difference in immune activation may predispose women to inflammation-associated disease.
Methods: Peripheral blood samples and small intestinal biopsies were obtained from 34 healthy men and women.
Immunophenotypic analysis of isolated lymphocytes was performed by flow cytometry. Oligonucleotide analysis
was used to study the transcriptional profile in the gut mucosal microenvironment while real-time PCR analysis was
utilized to identify differential gene expression in isolated CD4+ T cells. Transcriptional analysis was confirmed by
protein expression levels for genes of interest using fluorescent immunohistochemistry. Data was analyzed using
the GraphPad software package.
Results: Women had higher levels of immune activation and inflammation-associated gene expression in gut
mucosal samples. CD4+ and CD8+ T cells had a significantly higher level of immune activation-associated
phenotype in peripheral blood as well as in gut associated lymphoid tissue along with higher levels of proliferating
T cells. CD4+ T cells that showed upregulation of IL1β as well as the TH17 pathway-associated genes contributed a
large part of the inflammatory profile.
Conclusion: In this study, we demonstrated an upregulation in gene expression related to immune function in the
gut microenvironment of women compared to men, in the absence of disease or pathology. Upon closer
investigation, CD4+ T cell activation levels were higher in the LPLs in women than in men. Sex differences in the
mucosal immune system may predispose women to inflammation-associated diseases that are exacerbated
following menopause. Our study highlights the need for more detailed analysis of the effects of sex differences in
immune responses at mucosal effector sites.Background
Sex and gender-related differences are reflected in the vary-
ing magnitude of inflammatory or autoimmune diseases in
men and women and are attributed to the diversity of im-
mune responses to infectious or non-infectious stimuli in
men and women [1]. Women have a significantly higher* Correspondence: ssankara@ucdavis.edu
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mediated by humoral and adaptive immune responses [1].
It is likely that some of these effects in women are due to
the immune-modulatory effects of sex hormones [2-4].
Sex hormones play an important role in the develop-
ment of adaptive cellular immunity, especially following
repeated antigenic stimulus [5]. Gene expression profiling
of immune cells from women detected an increased ex-
pression of genes associated with inflammatory and cyto-
toxic T cell responses [5]. However, other studies reportedd Central Ltd. This is an Open Access article distributed under the terms of the
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[6]. Discordance among these findings might have been
influenced by the timing of the sample collection and
the hormonal milieu in women. Sex-specific immune
modulation is likely mediated by sex hormones through
activation of their specific receptors. Estrogen receptors
are expressed on T cells, macrophages and other im-
mune cells that are localized in several tissue compart-
ments in addition to the reproductive tract [7-10].
Estrogen directly modulates immune function through
cytokine production, cell activation, and cell proliferation
[7-10]. Estrogen is also shown to influence the immune
response to tissue injury [11,12]. While an enhanced im-
mune response can be protective against some infections,
this could also predispose women to more autoimmune
disease [13]. Sex-related differences in antibody produc-
tion, lymphocyte proliferation, and cytotoxic activity and
the influence of steroid hormones on these functions has
been previously investigated [13]. Peptide hormones in-
cluding prolactin, luteinizing hormone (LH), and follicle
stimulating hormone (FSH) enhance proliferation of lym-
phocytes in response to mitogenic stimuli.
Estrogen and progesterone stimulate their cytotoxic
activity by enhancing the release of reactive oxygen spe-
cies [14,15]. Recent gene expression analysis of isolated
peripheral blood mononuclear cells (PBMC) from men
and women showed a markedly increased expression of
immune response related genes in women. Levels of
inflammatory and cytotoxic response-associated genes,
including IFNγ, IL12Rβ2 and (Leukotriene) LTβ, were all
increased in women compared to men [5]. These find-
ings suggest sex-specific differences in T cell function
and regulation.
Despite extensive information regarding the effects of
sex hormones on immune cells, our knowledge is limited
regarding the effects of sex and gender on the function of
the gut mucosal immune system [14,15]. Most investiga-
tions focused on the analysis of the peripheral blood com-
partment. However, the gut-associated lymphoid tissue
(GALT) is the largest lymphoid organ in the body and is
an important site for host-microbe interactions. The in-
volvement of the GI tract is well documented in several
inflammatory and autoimmune disorders, including
Crohn’s disease, ulcerative colitis, and Celiac disease. It is
not known whether the regulation of intestinal inflamma-
tory response is influenced by sex differences [16]. Differ-
ences in immune cell infiltration of the colonic mucosa
such as mast cells have been shown to correlate with
symptomatic differences between the sexes in Irritable
Bowel Syndrome (IBS) [17]. However, no differences were
observed in healthy controls [17]. The reason for observed
gender differences has been attributed to sex hormones
and their effects on mast cells, but little is known regard-
ing the effects of sex on lymphocyte function [18]. Whilemany of these studies have been conducted in older
women in whom sex hormone levels are low, little is
known about sex differences between women and men of
younger age groups and if these sex differences play a role
in the development of inflammation-associated diseases
later on in life.
While studies in the colon have provided evidence for
the role of sex in mucosal immune responses, the jejunum
is one of the most cellular regions of the small intestine
with a large percentage of the body’s T cells. CD4+ T cells
are the cellular targets of viral infections such as HIV
where gender differences and sex hormones play an im-
portant role in pathogenesis and transmission kinetics.
Thus, the goal of this study was to investigate the link
between sex differences and the regulation of intestinal in-
flammation by analyzing jejunal biopsies and peripheral
blood samples from healthy age-matched male and female
participants. Since the gut mucosa is a site of interaction
between the gut microbiome and the host immune sys-
tem, we investigated the effect of sex differences on tran-
scriptional profiles of gut biopsies as well as isolated
mucosal CD4+ T cells. Our findings suggest that the sex
differences manifest as higher levels of immune activation
and inflammation in women compared to men in the ab-
sence of any disease or pathology, thus influencing gut
mucosal immune response and function.
Methods
Sample Collection
Healthy female participants were enrolled in the study at
the Center for AIDS Research, Education, and Services
clinic and at the Kaiser Permanente Clinic in Sacramento,
CA. Male participants were enrolled from the same
general geographical area as the female participants. The
inclusion criteria included: age between 20 and 60,
healthy, and able to participate in an upper GI endoscopy
procedure with minimal risk. The exclusion criteria for all
participants included: incidence of cardiovascular disease,
diabetes, smoking, excessive alcohol consumption, use of
illicit drugs or medications. Exclusion criteria specific to
female participants was a peri- or post-menopausal state
as defined by SWAN [19]. Samples were obtained during
the follicular phase of the menstrual cycle (4–7 days fol-
lowing last menstrual period). Menopause is associated
with changes in mucosal epithelial function which can
further augment observed gender based differences in im-
mune function. Thus postmenopausal state was an exclu-
sion criterion. Age also plays a role in immune responses
and to minimize the effects of age all participants enrolled
were under the age of 55. Over 40 potential participants
were reviewed by the research team and 34 fulfilled the
enrollment criteria. The study protocol was approved by
the UC Davis Institutional Review Board. All participants
provided written, signed informed consent. Twenty
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EDTA-containing tubes and processed at each time point.
Pinch biopsies were obtained by upper GI endoscopy from
the jejunum under conscious anesthesia according to pre-
viously published protocols [20]. All samples were col-
lected between 7:00 AM and 9:00 AM at the UCD
Gastroenterology Clinic, Sacramento, CA after overnight
fasting.
Isolation of peripheral blood mononuclear cells (PBMC)
Whole blood was collected in EDTA-containing tubes and
centrifuged for 20 minutes. The white blood cell buffy
coat was collected, diluted in 1X PBS, layered over ficoll
gradients (Atlanta Biological, Lawrenceville, GA), and
centrifuged 20 minutes. The mononuclear cell layer was
collected and pelleted by centrifugation. Cells were cul-
tured overnight at 37°C, 5% C02 in culture media (RPMI
1640 supplemented with 10% FBS, 100 U/mL penicillin/
streptomycin, and 1% L-glutamine (Gibco) [20]. Five to
seven million PBMC were used for CD4+T cell isolation.
Isolation of intestinal lymphocytes
Jejunum biopsies were placed in isolation media (RPMI
1640 supplemented with 10% fetal bovine serum (FBS), 100
U/mL penicillin, 100 U/mL streptomycin (Gibco, Grand
Island, NY) and collagenase type IIb (1 mg/mL) (Sigma, St.
Louis, MO) [20] and subjected to shaking at 37°C for four
periods of 30 minutes. Cells were washed with RPMI media
and rested overnight in culture media (RPMI 1640
supplemented with 15% FBS, 1% gentamycin, 100 U/mL
penicillin, 100 U/mL streptomycin, 1% L-glutamine, 1% so-
dium pyruvate, 2.5% Hepes, and 0.5% amphotericin B
(Gibco)) at 37°C with 5% CO2. Cells were filtered through a
40 μm filter the next day and counted. Three to four mil-
lion lymphocytes were filtered the same day for further
CD4+Tcell isolation.
CD4+ T cell isolation
Isolated lymphocytes from the jejunum and peripheral
blood were enriched for CD4+T cells by magnetic bead
sort (Dynal, Carlsbad, CA). Magnetic beads pre-coated
with CD8 antibody were incubated with isolated lym-
phocytes for 30 minutes at 4°C on a gentle rotating plat-
form and CD8 lymphocytes were collected by magnet
and incubated with CD13 coated magnetic beads. Pan-
mouse IgG beads (Dynal) were first incubated for 30 mi-
nutes at 4°C on a rotating platform with monoclonal
IgG CD13 antibody (BD, San Jose, CA), and then CD13
coated beads were incubated with CD8 depleted lym-
phocytes for 30 minutes at 4°C on a gentle rotating plat-
form. The CD8- CD13- lymphocytes were collected by
magnet, washed in culture media, and incubated over-
night at 37°C/5%CO2 at a maximum concentration of 2
million cells/ml. Cells were pelleted the following dayand stored in −80°C until use. Supernatant from over-
night culture was also stored at −80°C until needed.
Purity of PBMC (90-100%) and jejunal lymphocytes
(65-85%) was determined by flow cytometry.
Immunophenotypic analysis
Isolated lymphocytes (1 million cells/tube) were incubated
with Aqua (Amcyan) Live/Dead Dye (Invitrogen, Carlsbad,
CA) (0.5 uL/mL 1XPBS + 1million cells). Lymphocytes
were then washed with staining buffer (filter sterilized
1XPBS with 3% heat-inactivated FBS and 0.1% sodium
azide). Cells were incubated with 10% normal mouse
serum (Jackson Immunoresearch Laboratories, Inc) and
then with fluorescent mouse anti-human monoclonal anti-
bodies. CD3 (Beckton Dickinson, Mountain View, CA),
CD45RA, CD45RO, CD8 (Invitrogen), CD95 (Biolegend,
San Diego, CA), CD28, CD4, HLADR, Ki67 (E-Bioscience)
antibodies were used. Cells were washed and fixed with
1% paraformaldehyde (PFA) (Sigma) prior to analysis on
the LSR II flow cytometer (Beckton Dickinson at the UC
Davis core facility). The cells were first gated based on
negative staining with live dye, followed by a lymphocyte
gate. These populations were further analyzed by specific
staining. A minimum of 500,000 events was collected per
sample and data was analyzed using Flow Jo (Tree Star,
Inc. San Carlos, CA).
Stimulation assays
Isolated lymphocytes (~1 million cells) were stimulated
with phorbol 12-myristate 13-acetate (PMA) (1 ng/mL) +
Ionomycin (1 μM/mL) (Sigma), or negative control media
alone at 37°C with 5% CO2 for 6 hours. Anti-CD28 pure
monoclonal antibody (Ebioscience) was added to aid co-
stimulation, followed by addition of Brefeldin A (Sigma)
for the final 5 hours to prevent Golgi transport of cyto-
kines out of cells. Cells were washed with 1X PBS/1%BSA,
stained for surface markers, and fixed in 1% PFA. Fixa-
tive was washed out and cells were permeabilized with
Caltag Permeabilization Solution B (Invitrogen) and
stained with monoclonal antibodies IFNγ, IL-2, and
TNF-α (BD, Ebioscience) for 20 minutes at room tempe-
rature. Samples were washed and fixed with 1% PFA
before analysis with LSR II. A minimum of 500,000 events
were collected for each sample and analyzed using Flow Jo
software. Polyfunctional cell analysis was performed using
SPICE (v4.1.6) and PESTLE (v1.5.4) software courtesy of
Mario Roederer, Vaccine Research Center, NIAID/NIH,
Bethesda, MD.
Transcriptional analysis
Gene expression profiles in gut biopsies from partici-
pants were analyzed using microarray technology and
real-time PCR. In brief, total RNA was isolated from
cryopreserved jejunal tissue utilizing protocols and
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senger RNA amplification, labeling, hybridization to hu-
man whole-genome U95av2 GeneChips© (Affymetrix)
staining and scanning were performed as previously de-
scribed [21,22] utilizing kits and protocols described in
the Affymetrix Gene Expression Analysis Technical
Manual. Microarray data were analyzed cross-sectionally
amongst all groups utilizing the dChip (http://www.
hsph.harvard.edu/cli/complab/dchip/) software program.
A minimum fold-change of 1.5 (p-value ≤ 0.05) between
groups was established as a cut-off criterion for statis-
tical validation. Samples from male participants were
used as baseline values for identifying differentially
expressed genes (DEG) in samples from female partici-
pants. Pathway analysis was performed using Ingenuity
Pathway Analysis (IPA) (http://www.ingenuity.com)
software.
RNA was also isolated from CD4+ T cells enriched
from PBMC as well as LPL using the same methods as
in the microarray analysis. CDNA was synthesized using
Superscript III (Invitrogen, CA) and used in Taqman©
Real-Time PCR assay as previously described (Applied
Biosystems, CA) [21,22]. The data were normalized to
the housekeeping gene GAPDH and calibrated to the
average of the male samples from the same tissue
source. The data were presented as a fold increase in
RNA level compared to the calibrator [23].Immunohistochemistry
Immunohistochemical analysis (IHC) was performed to
detect and localize expression of IL17, TNFα, FoxP3 and
IL1β in the small intestinal mucosa. Jejunal biopsies
were embedded in paraffin blocks following fixation with
4% PFA. Tissue sections (5 μm) were incubated with
polyclonal anti-IL17, anti-TNFα, anti-FoxP3 or anti-IL1β
overnight at 4°C, followed by incubation with FITC-
labeled secondary antibodies for 1 hour as previously de-
scribed. Sections were mounted using SlowFade with
Dapi (Invitrogen, Carlsbad, CA). Images were captured
by confocal laser microscopy using LSM 5 and PASCAL
software (Zeiss, New York) and then analyzed using
Image J software, NIH, Maryland.Table 1 Characteristics of participants
Group ID Male Female
Number 12 22





Asian 2 0Statistical analysis
Data sets were analyzed using the two-tailed paired or
unpaired t-test as applicable, taking into account the dis-
tribution of the data (GraphPad Prism version 5.00 for
Windows, GraphPad Software, San Diego California USA,
www.graphpad.com). Due to the limited availability of
samples to perform all the analyses, a selected number of
samples were utilized in each assay over 75% overlap be-
tween most experiments. The real-time data were ana-
lyzed for statistically significant differences at the level ofthe calibrated values as well as at the level of the linearized
fold change representing relative expression.
Results
Demographics of study participants
Thirty-four study healthy participants were enrolled over
a period of 5 years; 22 were female, and 12 were male
(Table 1). Women were 23 to 52 years old, had not had
chemotherapy or radiotherapy, had intact ovaries and
uterus, and were not on hormonal contraceptives during
or prior to sample collection. Men were age-matched to
female participants. There were no significant differ-
ences between plasma estradiol levels within the group
of women. Female participants had a mean plasma estra-
diol level of 126 pg/ml (Range 102-140 pg/ml). Men and
women did not differ significantly in age or race/ethni-
city distributions. All participants completed a health
survey prior to sampling. No significant differences were
observed in the answers and all participants appeared to
be healthy; however latent viral infections could not be
ruled out.
Baseline gut mucosal gene expression shows increased
immune activation and inflammation in women
compared to men
The transcriptional profile of the gut microenvironment
was studied by oligonucleotide microarray analysis.
Hierarchical cluster analysis showed that the samples from
male participants were similar in their gut mucosal gene
expression profile and clustered together, while the
samples from female participants clustered together
(Figure 1A). In general, the majority of gut mucosal genes
that were differentially expressed between men and
women were expressed at higher levels in women as com-
pared to men (1903 increased in women vs 889 increased
in men). Further analysis of the 1903 upregulated genes in
women grouped them in statistically significant functional
clusters that included genes associated with cancer, IGF-1
signaling as well as other immune signaling pathways
(Figure 1B) (p<0.05). Between 20 and 100 different gene
transcripts were identified within these pathways, indicat-
ing a pattern of gene regulation associated with activation
in the gut microenvironment.
Figure 1 The microenvironment of the gut in women has a transcriptional profile indicative of increased activation and turnover.
Transcriptional analysis of jejunal mucosa was performed using oligonucleotide microarray analysis. (A) All samples cluster in accordance with the
gender of the participant. A large portion of the gene expression included genes that were upregulated in women as compared to men (B) The
genes that were upregulated clustered into functional categories of IGF-1 signaling, Integrin Signaling and other signaling pathways (p<.05).
Sankaran-Walters et al. Biology of Sex Differences 2013, 4:10 Page 5 of 12
http://www.bsd-journal.com/content/4/1/10The largest cluster of genes that was increased in
abundance in the microenvironment of the gut in fe-
males included genes involved in inflammation and im-
mune activation (Figure 2A). Further analysis of these
genes showed that the IL1 signaling cascade was
upregulated with an increase in expression of IL1, IL1R,
MY88 and NF-κB (Figure 2B). Increased levels of IL 1β
were also observed at the protein level by immunohisto-
chemical analysis in women compared to men (Figure 3G,
H, I). IL2 receptor β and γ expression was increased in
women compared to men. Genes belonging to the STAT3
signaling pathway as well as SOCS1 were also upregulated
in women (Figure 2C). Interestingly, multiple gene tran-
scripts involved in antigen presentation were also expressed
at higher levels in women as compared to men. Further de-
tailed analysis of the transcriptional data indicated that the
downstream effectors of CD8+ T cell function, such as
IFNγ were also increased at the transcriptional level in
women. Many of these changes may be attributed to small
differences in the cellular population; however no signifi-
cant differences were observed in actual percentages of
lymphocytes between men and women.Increased levels of RNA transcripts associated with cel-
lular proliferation were observed in women compared to
men. These transcripts could be reflective of the prolifera-
tive/regenerative nature of the gut microenvironment.
Wnt β-Catenin signaling pathway is important in epithe-
lial regeneration and this pathway was transcriptionally up
regulated in the jejunal mucosa in women (Figure 4A).
Also involved in cell cycle regulation, the G1/S checkpoint
regulation associated genes were increased in women
(Figure 4B). Thus, it appeared that increased transcription
in the gut mucosa in women was association with cell pro-
liferation and immune activation.
Women have higher levels of T cell proliferation and T
cell activation in peripheral blood and gut of women in
the absence of disease
To identify the cells contributing to increased immune
activation and the proliferation profile observed in
women, T cell proliferation in the peripheral blood and
gut mucosa was measured by flow cytometry using Ki67
antibody. Higher levels of Ki67+ CD4+ T cells were ob-
served in women compared to men in peripheral blood
Figure 2 Pathways associated immune activation are upregulated in the gut mucosa in women. (A) A large cluster of the increased levels
of gene transcription in the mucosal microenvironment includes genes and pathways associated with immune activation, antigen presentation
and inflammation (M: male, F:female). Specific pathways that were upregulated in the microenvironment of the female gut mucosal tissue over
baseline of male mucosal tissue include (B) IL1 Signaling, (C) IL2 Signaling and (D) Antigen presentation (Red: Increase in expression, Green:
decrease in expression).
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are the means of the values in each group. Interestingly,
within women the level of CD4+ Ki67+ T cells was sig-
nificantly higher in Lamina Propria Lymphocytes (LPLs)
than in PBMCs which may be indicative of the increase
in activation state in the LPLs as compared to PBMCs
(mean 3.386% vs 1.852%) (p=.011). Women also had
higher levels of proliferating CD4+ T cells the gut (LPL:
3.386% vs .42%) compared to men. Women, also had
significantly higher levels of Ki67+ CD8+ T cells in the
LPLs as well as in PBMCs compared to men (PBMC:
1.775% vs .14%, LPL: 3.181% vs .77%). A positive correl-
ation was observed between CD8+ HLADR and Ki67 ex-
pression in male LPL but not in PBMC or in samples
from women. The data in women appeared to have a
greater spread than in men. No significant differences ingeneral health were observed within the group of fe-
males participants.
The percentage of T cells expressing the activation
marker, HLA-DR, was determined using flow cytometry
(Figure 5B). The percentage of activated CD4+ T cells in
peripheral blood of women was significantly higher than
in men (p=.0014). The percentage of HLA-DR express-
ing activated CD8+ T cells was also increased in women
compared to men with a mean difference of 19.23
(p=.0006). This increase in T cell activation in peripheral
blood is also reflected in GALT. The percentage of cells
that were CD4+ HLA-DR+ in the LPL was also higher
in women compared to men, indicating that cell activation
in women was higher than in men (p=.0195), and CD8+ T
cell activation was also higher in women compared to
men (p=.0078). A positive correlation (p>.05) was
Figure 3 Immunohistochemical analysis of jejunal mucosal samples. Tissue sections were stained for TNFα, IL17 and IL1β. A higher number
of cells were observed that were positive for TNFα in women (3B) compared to men (3A). Quatitation for the mean fluorescence intensity of the
tissue section showed similar results (3C). Women also had higher levels of IL17 + cells in the villus compared to men (3E vs 3D). On
quantitation of mean fluorescence intensity within the villus, women had significantly higher levels compared to men (3F). IL1β staining in the
jejunal mucosa in women was higher than in men (3G, H and I). No staining was observed in antibody negative controls. All images were
obtained at a 63X magnification. (* = p<.05). Nucleus in blue; Antibody Positive cell in red.
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expression in all groups in PBMC as well as LPL.
LPL derived CD4+ T cells from women are also more
sensitive to non-specific stimulation with PMS/Ionomycin
as compared to men. LPL and PBMC were stimulated
with PMA/Ionomycin and TNFα levels were measured by
intracellular staining and flow cytometry (Figure 5C). In
general, a higher level of responsiveness was observed in
LPLs of all study participants, male and female. However,
CD4+ cells from women had higher levels of TNFα in the
LPLs than in men (41.61% vs 28.8%) (p<0.05). No signifi-
cant differences were observed in CD8+ T cells from the
blood or gut. Surprisingly, the percentages of CD8+ T cell
producing TNFα on stimulation in the gut was signifi-
cantly lower than that in the peripheral blood in women,
but not in men. Increased expression of TNFα protein
was also detected the gut tissue of women by immunohis-
tochemistry (Figure 3A, B and C).Gut mucosal CD4+ T cells contribute to the elevated Th17
associated inflammatory profile in women
CD8 T cells from women, despite having higher levels of
HLA-DR compared to men, showed lowered responsive-
ness to non-specific stimulation. CD4+ T helper cells
play an important role in the adaptive immune system,
especially in the gut. To determine if the CD4+ T cells
contributed to the immune activation in women, mRNA
profiling was performed in CD4+ T cells enriched from
peripheral blood and the gut mucosa. Increased tran-
script levels of CCL5 (RANTES) were detected in
isolated CD4+ T cells from the blood and gut (Figure 6).
In addition to CCL5, IFNγ and TNFα transcript levels
(Figures 7) were also significantly increased in women
compared to men as measured by real-time PCR assay,
as well as at the protein level as detected by flow cytome-
try and immunohistochemistry (Figure 3C, 6A, B and C)
Tumor necrosis factor ligand superfamily 10 is a factor
Figure 4 Microarray analysis also indicated an increase in Wnt signaling and cell cycle regulation in women. (A) Increased turnover of
epithelial cells is associated with an increase in expression of genes in the Wnt β Catenin signaling pathway with downstream nuclear effectors
such as SOX, HDAC1. (B) A compensatory increase in cell cycle regulation via the G1/S Checkpoint was also observed at the transcriptional level.
(Red: Increase in expression, Green: decrease in expression).
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its receptors has been shown to activate of MAPK8/JNK,
caspase 8, and caspase 3, thus inducing cell death.
TNFS10 transcript levels increased in the blood but not
significantly in the gut. IL1β transcripts were increased in
the microenvironment of the gut mucosa as well as in iso-
lated CD4+ T cells. It is likely that the activated CD4+ T
cells contribute to the inflammatory profile observed in
women in the gut as well as in peripheral blood.
The CD4+ T cells also showed a significant increase in
expression of FOXP3 as well as TGFβ in women com-
pared to men (p<.05) (Figure 7). In both cases the LPLs
tended to have higher expression than PBMC-derived
CD4+ T cells, but this increase was not statistically sig-
nificant. These observations could be due to a compen-
satory response to increased immune activation in CD4+
cells. IHC for Fox P3 demonstrated significantly higher
numbers of FOXP3+ cells in villi of women compared to
men as well as increased expression in positive cells
(Figure 7C, D, E).
The gut mucosa is a site of complex host-microbe inter-
actions. The Th17 response is a characteristic of an effect-
ive immune response against pathogenic bacteria present
in the intestinal lumen. IL17 is induced by a complex sig-
naling pathway and contributes to inflammation. IL17 ex-
pression is several-fold higher in CD4+ T cells from
women as compared to men (128 fold in CD4+ T cells in
PBMC, 26-fold in CD4+ T cells in LPL). RORγ (RORC)
and STAT3 are upstream inducers of IL17, while Lipocalin
and iNOS are downstream inducers of inflammation
whose expression depends on IL17. These genes are
expressed at higher levels in women compared to men,
especially in CD4+ T cells derived from the gut. SOCS3, anegative regulator of IL17 is also induced, likely in
response to the strong induction of IL17 in women
(Figure 8). IL17 levels in gut tissue were also increased in
women, which were localized to the lamina propria and to
a lesser extent the epithelium (Figure 3D, E and F). How-
ever, there was no significant correlation between the ex-
pressions of Th17 associated genes.
Discussion
Sexual dimorphism of the immune system plays an import-
ant role in disease occurrence, host-microbe interactions,
and mechanisms of pathogenesis [6]. Females respond to
infections with a more robust innate and adaptive immune
response compared to males. This, however, is a double-
edged sword. For some infections, this can be beneficial
because it results in faster clearing of the pathogen. In
others, such as H1N1 influenza virus, the robust immune
response may result in a greater number of fatalities in fe-
males compared to males. Increased immune activation
may potentially place females at a greater risk of develop-
ing autoimmune disorders.
In this study, we demonstrated an upregulation of
gene expression related to immune function in the gut
microenvironment of women compared to men in the
absence of any current disease or pathology. Upon closer
investigation, CD4+ T cell activation levels were higher
in the LPLs in women than in men. Prior studies have
demonstrated an increased immune response in women
following nonspecific stimulation of the peripheral blood
[5]. However, the gut mucosal immune system is the lar-
gest in the body. The gut is also the most important site
of host-microbe interactions. It is likely that the height-
ened responsiveness in the gut is triggered by the need
Figure 5 Women have higher levels of Ki67+ T cells as well as activated T cells in peripheral blood and GALT as measured by flow
cytometry. (A) Ki67+ cells are in the process of proliferation. (B) Higher levels of T cell activation in women as compared with men in peripheral
blood and GALT measured as % of HLA-DR+ T cells. (C) Following PMA ionomycin stimulation a higher percentage of CD4+ T cells produce
TNFα in women than in men. (* = p<.05).
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and may be driven by gender associated differences in
that process. Our study demonstrated sex differences in
the mucosal immune system in which women had a
higher baseline level of immune activation compared to
their male counterparts thus predisposing them to
inflammation-associated diseases that are exacerbated
following menopause.
Studies in murine models of burn injury indicate that
higher estrogen levels in female mice contribute to im-
proper cell-mediated immune response to injury with an
aberrant inflammatory response that increases mortality.In contrast, male mice are immunosuppressed following
hemorrhagic injury and are more likely to suffer from
sepsis than female mice with a comparatively enhanced
cellular immune response under the same conditions
[24]. In our study, healthy women had an enhanced in-
flammatory response (IL1β pathway) as well as an im-
mune proliferative response (IL12 pathway) in the small
intestinal mucosa, which may be protective in some
cases of injury. Furthermore, an increase in TNFα and
IFNγ, likely to originate from the T cells in the LPLs fol-
lowing mitogenic stimulation, was evidence of a robust
cellular immune response in women as compared to
Figure 6 The activation profile seen in peripheral blood and gut is matched by the increase in transcription of activation and
inflammation associated genes (CCL5/RANTES, IFNγ, TNSF10 and TNFα, IL1β) in CD4+ T cells of women compared to men. Real Time
PCR analysis of CD4+ T cells enriched from the PBMC and LPL of women showed a significant increase in transcription of proinflammatory
factors such as CCL5 (A), IFNγ (B), IL1β (C), TNSF10 (D), and TNFα (E). (* = p<.05).
Sankaran-Walters et al. Biology of Sex Differences 2013, 4:10 Page 10 of 12
http://www.bsd-journal.com/content/4/1/10men in our samples. This occurred both at the level of
the gut microenvironment as well as the cellular level in
CD4+ T cells.
Prior studies reported that following mitogenic stimu-
lation, IL17A expression was upregulated in menFigure 7 Increased expression of Treg associated genes in enriched C
CD4+ T cells are necessary to balance the inflammation and immune activ
expression are hallmarks of Regulatory T cells. Transcriptional analysis by Re
women compared to men as well as TGFβ (B). (* = p<.05). Increased numb
in women compared to men (C, D, E) (Nucleus in blue, FOX P3 in Red).compared to women in PBMC [5]. In our study, we
showed a steady state increase of IL17A expression in
CD4+ T cells of women compared to men. IL17A is pro-
duced by both CD4+ and CD8+ T cells. In a limited
number of patient samples, increased IL17 MFID4+ T cells in females compared to males. The regulatory effects of
ation normally stimulated by CD4+ T cells. . FOXP3 and TGFβ
al-Time PCR indicates that (A) FOXP3 is expressed at higher levels in
er of FOX P3 positive cells were also observed by IHC with higher MFI
Figure 8 Upregulation of IL17 pathway associated genes in women compared to men in peripheral blood and gut CD4+ T cells. This
transcriptional profile in CD4+ T cells in the blood and gut may contribute to inflammation and immune activation in the gut in women.
(* =p<.05).
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http://www.bsd-journal.com/content/4/1/10following mitogenic (PMA/Ionomycin) stimulations was
detected in PBMC of men than of women (data not
shown). In CD4+ T cells, expression was increased of
transcription factors upstream of IL17A acivation, such
as RORC and STAT3, as well as downstream effectors
such as iNOS and Lipocalin. Th17 responses in infec-
tious diseases, such as HIV infection, are important in
controlling mucosal pathogenesis. In animal models,
basal Th17 levels may play a role in disease progression.
A basal gender-based difference in TH17 expression
may contribute to gender differences observed in disease
progression in viral and bacterial infection. This increase
in baseline cellular immune response could be protective
during infections but the lack of resolution may be detri-
mental in the development of autoimmune diseases.
Estradiol in women plays an important role in the re-
pair and regeneration of mucosal surfaces. In healthy
women, the Wnt signaling pathway is upregulated, indi-
cating an increase in turnover and regeneration of the
gut mucosa, likely of the epithelial cells. Wnt/β Catenin
signaling is important for the differentiation andmaturation of gut epithelial stem cells into mature
enterocytes as well as Paneth cells in crypts. The in-
crease in expression of transcripts belonging to this
pathway could also support the concept of increased
proliferation and turnover of epithelial cells in women as
compared to men. This may also indicate baseline differ-
ences in epithelial integrity between males and females.
These findings warrant further investigation.
Despite the small sample size in our study, it has iden-
tified inherent differences in the gut mucosal immune
system based on the sex and gender of the participant
and has pointed to an important concept relevant to
large-scale patient studies of drug efficacy or immune
modulators. It was not feasible to perform all cellular and
molecular analyses on all samples due to limitations asso-
ciated with sample collection. It was beyond the scope of
this study to identify latent viral infections such as EBV
and CMV that may drive immune activation in health
adults and can be investigated in future studies. The gut
microbiome also plays an important role in the immune
homeostasis. While microbiome differences may exist
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http://www.bsd-journal.com/content/4/1/10between the sexes, such studies have not been performed
in detail. Thus, similar studies using animal models may
be necessary to further delineate the effects of sex on gut
mucosal function. Our study is the first study to demon-
strate the baseline differences in the function of GALT,
the largest lymphoid tissue in the body.
Taken together with the knowledge that sex-based dif-
ferences in the immune system play an important role in
disease progression in infectious disease and vaccine re-
sponses, sex of the study population should be consid-
ered during clinical trials [25]. Our study highlights the
need for more extensive and detailed analysis of the ef-
fects of sex differences in immune responses at mucosal
effector sites.
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